4 European Projects Found
Searched on 125080 European Projects
FINISHED
Targeted disease prophylaxis in European fish farming (TargetFish)
Start date: Oct 1, 2012, End date: Sep 30, 2017,
European aquaculture production provides direct employment to 65.000 people with a turnover of 3 billion €. However, the lack of authorised veterinary medicinal products and the consequent disease outbreaks in farmed fish species costs the sector 20% of the production value. The most appropriate method for disease control, both on economical and ethical grounds, is disease prevention by vaccinatio ...
Read Project
32
Partners Participants
FINISHED
ANTIcipating the Global Onset of Novel Epidemics (ANTIGONE)
Start date: Nov 1, 2011, End date: Oct 31, 2016,
In recent years, an increased number of zoonotic viruses and bacteria have crossed the species barrier to humans and caused or threatened to cause human pandemics with high morbidity and mortality. Because of our inability to predict the emergence of these pathogens, it is difficult to take preventive measures. It is known that zoonotic pathogens need to cross barriers at the animal-human interfac ...
Read Project
14
Partners Participants
FINISHED
Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY)
Start date: Oct 1, 2009, End date: Sep 30, 2014,
"Bovine Spongiform Encephalopathy (BSE) started, 20 years ago, a devastating health and food crisis throughout Europe. Classical BSE is now under control as a result of the meat and bone meal ban. However, tonsil analyses suggest that there may be an alarmingly high number of asymptomatic PrPSc positive cases. Transmission through blood transfusion is another important concern, as are recent “atyp ...
Read Project
21
Partners Participants
FINISHED
European Research Infrastructure on Highly Pathogenic Agents (ERINHA)
Start date: Nov 1, 2010, End date: Aug 31, 2014,
In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be well-prepared to face such threats. However, the Biosafety Level 4 (BSL4) capacity in Europe is not sufficient enough to cover the efficient development of diagnosis, prophylactic and therapeutics means against these pathogens. Moreover, there is no global co ...
Read Project
